Literature DB >> 7110382

The effects of metoclopramide on acetylcholine release and on smooth muscle response in the isolated guinea-pig ileum.

H Kilbinger, R Kruel, I Pfeuffer-Friederich, I Wessler.   

Abstract

The effects of metoclopramide on smooth muscle contraction and on release of acetylcholine were studied in the guinea-pig myenteric plexus longitudinal muscle preparation. Acetylcholine was determined either as endogenous acetylcholine, or as labelled transmitter from strips preloaded with 3H-choline. Metoclopramide caused an increase in resting tension of longitudinal muscle as well as an increase in resting output of either endogenous or labelled acetylcholine. Tetrodotoxin abolished the metoclopramide-evoked increase in transmitter release. The increase in smooth muscle tension was clearly related to the increase in resting output. The effects of metoclopramide on both longitudinal muscle contraction and resting release of labelled acetylcholine were prevented in the presence of a concentration of 5-hydroxytryptamine (5-HT) that desensitized 5-HT receptors. This suggests that metoclopramide stimulates neuronal 5-HT receptors and, thereby, facilitates acetylcholine release. Metoclopramide augmented the twitch-like contractions induced by field stimulation at 0.1 Hz. Contractions elicited at 1 Hz were only slightly enhanced. Similarly, metoclopramide facilitated only the release of labelled acetylcholine evoked by electrical stimulation at 0.1 Hz, but not that at 1 Hz. The facilitatory effects of metoclopramide on twitch height and evoked release could not be attributed to a blockade of presynaptic inhibitory alpha-adrenoceptors, dopamine or muscarine receptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7110382     DOI: 10.1007/bf00495871

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

Review 1.  Metoclopramide.

Authors:  K Schulze-Delrieu
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

Review 2.  A comparison of the vascular dopamine receptor with other dopamine receptors.

Authors:  L I Goldberg; P H Volkman; J D Kohli
Journal:  Annu Rev Pharmacol Toxicol       Date:  1978       Impact factor: 13.820

3.  Formation and release of acetylpyrrolidinecholine (N-methyl, N-acetoxyethylpyrrolidinium) as a false cholinergic transmitter in the myenteric plexus of the guinea-pig small intestine.

Authors:  H Kilbinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-01       Impact factor: 3.000

4.  Receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart.

Authors:  J R Fozard; A T Ali
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978 Jan-Feb       Impact factor: 3.000

5.  Effect of metoclopramide on guinea pig stomach: critical dependence on intrinsic stores of acetylcholine.

Authors:  A M Hay; W K Man
Journal:  Gastroenterology       Date:  1979-03       Impact factor: 22.682

6.  Pharmacological difference of L-dopa, apomorphine, and bromocriptine against metoclopramide.

Authors:  V S Fang
Journal:  Life Sci       Date:  1981-05-11       Impact factor: 5.037

7.  Blockade of neuronal tryptamine receptors by metoclopramide.

Authors:  J R Fozard; A T Mobarok ALI
Journal:  Eur J Pharmacol       Date:  1978-05-01       Impact factor: 4.432

8.  Direct evidence of acetylcholine releasing effect of serotonin in the Auerbach plexus.

Authors:  V Adám-Vizi; E S Vizi
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

9.  Pharmacological analysis of the effects of metoclopramide on the transmurally stimulated guinea-pig ileum.

Authors:  J Fontaine; J Reuse
Journal:  Arch Int Pharmacodyn Ther       Date:  1979-11

Review 10.  Metoclopramide: a review of its pharmacological properties and clinical use.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more
  17 in total

1.  Studies on the pharmacological control of gastric emptying in man.

Authors:  D N Bateman
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

2.  Field stimulation-induced responses of circular smooth muscle from guinea-pig stomach. Characterisation of the receptor mechanisms involved.

Authors:  B Costall; R J Naylor; C C Tan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

3.  The signaling of amitriptyline-induced inhibitory effect on electrical field stimulation response in colon smooth muscle.

Authors:  Tin Sandar Zaw; Phyu Phyu Khin; Uy Dong Sohn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-28       Impact factor: 3.000

4.  The effect and mechanism of the prokinetic action of cisapride on gastrointestinal smooth muscle.

Authors:  H T Chen; M H Goh; S Pan
Journal:  Gastroenterol Jpn       Date:  1993-04

5.  Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924.

Authors:  G J Sanger
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

6.  Effect of metoclopramide, ondansetron and granisetron on aldosterone secretion in man.

Authors:  D K Sommers; J R Snyman; M van Wyk
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Regionally selective cholinergic stimulation by BRL 24924 in the human isolated gut.

Authors:  T A Burke; G J Sanger
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

8.  An ubiquitous modulating function of rabbit tracheal epithelium: degradation of tachykinins.

Authors:  K Inoue; Y Sakai; I Homma
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

9.  Two types of receptors for 5-hydroxytryptamine on the cholinergic nerves of the guinea-pig myenteric plexus.

Authors:  H Kilbinger; I Pfeuffer-Friederich
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

10.  Gastroprokinetic properties of the benzimidazolone derivative BIMU 1, an agonist at 5-hydroxytryptamine4 and antagonist at 5-hydroxytryptamine3 receptors.

Authors:  C A Rizzi; A Sagrada; A Schiavone; P Schiantarelli; R Cesana; G B Schiavi; H Ladinsky; A Donetti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.